Friday, May 16, 2025

20M UNCONTROLLED DM1 Telangana PaJR

 

13-05-2025

THIS IS AN ONLINE E LOG BOOK TO DISCUSS OUR PATIENT'S DE-IDENTIFIED HEALTH DATA SHARED AFTER TAKING HIS SIGNED INFORMED CONSENT. HERE WE DISCUSS OUR PATIENT'S PROBLEMS THROUGH SERIES OF INPUTS FROM AVAILABLE GLOBAL ONLINE COMMUNITY EXPERTS WITH AN AIM TO SOLVE THOSE PATIENT'S CLINICAL PROBLEMS WITH COLLECTIVE CURRENT BEST EVIDENCE BASED INPUTS.

18M WITH POST COVID FULMINANAT HEPATIC FAILURE.

 

JANUARY 12, 2023.

18 year old male ,From Miryalguda who completed his 12th standard presented to the casualty on 12/6/2021 with chief complaints of:

Low back ache since 1 week

Generalised weakness and loss of appetite since 1week

History of fever since 5days ,subsided now

Yellowish discolouration of eyes since 3 days

High coloured urine since 1 day

History of present illness

-Patient was apparently asymptomatic one year ago, then he visited a dentist in view of toothache and got it removed in view of caries tooth

-Since 6 months, patient had history of weight loss.

-History of nocturia ,polyuria and polydipsia since 2 months.(he used to get up atleast 6-7 times after he was asleep for micturation).

-10 days ago, patient attended a marriage function along with his family and after 2 days he complained of low back ache and 2 episodes of vomitings and 3 episodes of loose stools for one day which subsided on its own

-Next day pt developed fever which was intermittent ,high grade ,no chills and rigors and subsided with medication(rm) . Associated with loss of appetite and nausea and low back ache.

-After 2 days he noticed yellowish discoloration of eyes. So he visited a nearby hospital which showed elevated total bilirubin and his sugars were 360mg/dl.

-He was started on OHA by RMP and he used it for 3 days.

-Later they visted to our casualty in view of increase in yellowish discoloration of eyes and high colored urine.

-No history of excessive salivation ,dysphagia, vomitings, and black stools or blood in stools.

-No history of constipation/ diarrhea.

-No pain abdomen or distension.

-Clay colored stools present.

-No bleeding manifestations like purpura , petechiae, bleeding gums.

-No sob, pedal edema, chest pain.

PAST HISTORY :

-No history of similar complaints in the past.

-Not a k/c/o HTN,DM,TB,ASTHMA ,EPILEPSY.

-History of febrile seizures at 9 months of age.

-He was full term baby born at hospital ,cried immediately after birth, no history of jaundice at birth/childhood.

-No developmental delay and no cognitive impairment.

DRUG HISTORY:

-No history of usage of herbal medications.

-No history of drug intoxication.

PERSONAL HISTORY:

He has mixed diet , loss of appetite present, regular bowel and bladder movements .Adequate sleep.

No addictions ( alcohol and smoking ).

NO SIGNIFICANT FAMILY HISTORY 

…………………………………

GENERAL EXAMINATION 

Patient was conscious .co-operative coherent.

Oriented to time place and person.

Moderately built and nourished

ICTERUS - PRESENT.

No pallor ‚cyanosis ,lymphadenopathy ,clubbing and odema .

No raised JVP

Vitals on presentation:

  • BP- 110/70 mmgh supine posture in right arm
  • PR - 94 bpm regular .normovolemic
  • Rr - 24cpm ; spo2 - 100% on RA.
  • GRBS -287mg/dI TEMP- 99 F

SYSTEMIC EXAMINATION

Head to Toe examination:

  • No alopecia, bitot spots, subconjunctival hemorrhages, kayser-
    Fleischer ring, no fetor hepaticus, no bleeding gums.
  • No spider naevi, gynecomastia, loss of axillary hair, caput medusa, testicular atrophy, dilated veins on abdomen, wasting,
  • No leukonychia, palmar erythema, flapping tremor.
  • No pedal edema

Systemic examination:

Per abdomen :INSPECTION

Shape of the abdomen - scaphoid

Umbilicus - central in position and inverted.

No scars ,sinus ,dilated veins.

PALPATION:

Mild Tenderness noted in right hypochondrium.

No palpable mass.

No guarding and rigidity

No organomegaly

PERCUSSION:

Liver span - 11 cms

No fluid thrill

AUSCULTATION:

Bowel sounds present.

No bruit heard


CVS - sI $2 heard . No murmurs

RS - bilateral air entry present,Normal vesicular breath sounds.,No adventitious sounds.

CNS;NO FND

PROVISIONAL DIAGNOSIS

?Acute viral hepatitis

Denovo DM

INVESTIGATIONS-

From 11-6-2021 to 16-6-2021



His total bilirubin has increased to 16 on 16/6/2021 (day 6 of admission) but with normal liver enzymes (AST, ALT).
Hepatitis as a differential was confusing as the SGOT, SGPT were completely normal till day 7 of admission.
Hemolysis and intra hepatic cholestasis were considered as Hb dropped from 16 to 13, both direct and indirect bilirubin have increased

17-6-2021 to 22-6-2021

 

Further drop in Hb to 11.5, total bilirubin increased to 14.

From day 8 of admission SGOT and SGPT gradually started increasing.

23-6-2021 to 29-6-2021



CT brain and CECT abdomen were done during his course in hospital when required.

COURSE IN THE HOSPITAL-

18 YEAR OLD MALE CAME WITH C/O LBA ,YELLOWISH DISCOLORATION OF EYES,FEVER SINCE 4-5 DAYS PT. WAS ADMITTED AND NECESSARY INVESTIGATIONS WERE SENT. Pt WAS FOUND TO HAVE ISOLATED HYPERBILIRUBINEMIA(6.7TB )PREDOMINANTLY INDIRECT AND ENZYMES WERE NORMAL .HIS URINE FOR KETONES WERE POSITIVE WITH RBS 280 AND MILD ACIDOSIS .SO TH PT WAS DIAGNOSED AND TREATED AS DKA (DENOVO DETECTED TYPE 1DM),HYPERBILIRUBINEMIA UNDER EVALUATION,WITH COAGULOPATHY.

USG ABDOMEN -LIVER NORMAL ECHOTEXTURE,CBD NORMAL ,NO EVIDENCE OF IHBRD

DAY1-

PT WAS TREATED WITH INSULIN AND IV FLUIDS,VIT K

DAY2-

HIS SUGARS CAME INTO CONTROL ON DAY2 OF ADMISSION .HIS INSULIN REQUIREMENT WAS AROUND 12 UNITS ACTRAPID PER DAY .PT CONTINUED TO HAVE LBA

XRAY LS SPINE WAS DONE WHICH WAS NORMAL

DAY3-

PT COMPLAINS OF LBA AND LOSS OF APPETITE AND DID NOT PASS STOOLS SINCE 1 DAY

SUPPORTIVE MANAGEMENT WAS GIVEN ,SYP LACTULOSE WAS GIVEN

DAY4-

PT COMPLAINED OF SEVERE GENERALISED WEAKNESS

BY AROUND EVNG 6 PM , PT BECAME DROWSY NOT RESPONDING TO VERBAL COMMANDS .HIS SENSORIUM DETERIORATED JUST OVER 1-2HOURS.(?HEPATIC ENCEPHALOPATHY) WITH ACUTE RETENTION OF URINE AND BIZARRE STAREY LOOKS ,RESPONDING TO PAINFUL STIMULI ?ABSENCE SEIZURES ,INJ. LORAZ 2CC GIVEN.VITALS WERE STABLE

SERUM ELECTROLYTES CAME NORMAL.

IN VIEW OF COAGULOPATHY CT BRAIN WAS DONE TO RULE OUT IC BLEED

CT BRAIN NORMAL

PT DID NOT PASS STOOLS SINCE 2 DAYS ,ENEMA WAS GIVEN

PT PASSED STOOLS AFTER ENEMA

FOLEYS CATHETERISATION WAS DONE ,COLA COLORED URINE OF ABOUT 1000 ML WAS COLLECTED IN UROBAG

Question: 18year old male with acute liver failure(?toxin mediated,?immune medaited) with hepatic encephalopathy, coagulopathyWith cola coloured urine(?hemoglobinuria)

Acute hemolysis ?toxin mediated

Hb dropped from 16 to 13mg/dl

LDH 888

URINE WAS SENT FOR ANALYSIS, URINE FOR PORPHOBILINOGEN NEGATIVE, NO RBCs IN URINE

UROLOGY REFERRAL WAS TAKEN IN VIEW OF 5MM RIGHT RENAL CALCULUS ,ADVISED FOR XRAY KUB AFTER STABILISATION

DENGUE SEROLOGY NEGATIVE,SMEAR FOR MP 

?AUTOIMMUNE HEMOLYTIC ANEMIA

DCT ICT NEGATIVE 

DAY5-

GCS- E2V2M3

PT COMATOSED WITH B/L REACTING PUPILS, DILATED

VITALS STABLE, DEEP TENDON REFLEXES NORMAL WITH B/L EXTENSOR PLANTAR

WITH SUSPICION OF CEREBRAL MALARIA ,INJ.FALCIGO 120 MG STAT. GIVEN(0----12---24--48 HRS), 4 DOSES GIVEN,INJ. LEVIPIL 500 MG BD WAS STARTED ,INJ. DOXYCYCLINE 100 MG BD WAS STARTED

OTHER SUPPORTIVE MEASURES WERE GIVEN SUCH AS IV FLUIDS ,SYP.LACTULOSE,ENEMA WERE GIVEN

HIS TB SHOOT UP TO 15 ,DB 6,IB 9,AST 18,ALT 22 ,ALP 138,TP 7.6,ALB 4,HB 13,(IT WAS 16 GM AT THE TIME OF ADMISSION )

DIFFERENTIAL DIAGNOSIS-

?CEREBRAL MALARIA

?ACUTE HEMOLYSIS(INTRAVASCULAR)

? ACUTE LIVER FAILURE 

? ACUTE INTERMITTENT PORPJHYRIA

HEPATIC ENCEPHALOPATHY WITH METABOLIC SEIZURES AND COAGULOPATHY

DKA (RESOLVED),DENOVO DETECTED ?TYPE 1 DM

DAY 6-

GCS-E2V1M3 WITH B/L REACTIVE PUPILS AND VITALS STABLE

SERUM LDH-237

SERUM IRON 150 ,SERUM FERRITIN> 1500,HBA1C 6.6,TSH 1

TRIPLE PHASE CT ABDOMEN WAS DONE TO RULE OBSTRUCTIVE PATHOLOGY WHICH SHOWED FATTY LIVER NO IHBRD ,NORMAL CBD ,NORMAL HEPATIC VEINS IVC,INCIDENTALLY DETECTED SMALL BOWEL INTUSUSSCEPTION

AS THERE IS NO OBSTRUCTIVE PATHOLOGY,THE REASON FOR RAISING INDIRECT BILIRUBIN ,FALL IN HB,RAISE IN SERUM LDH CAN BE CONSIDERED AS COOMBS NEGATIVE HEMOLYTIC ANEMIA AND THE REASON FOR RAISE IN DIRECT BILIRUBIN DUE TO INTRA HEPATIC CHOLESTASIS

PERIPHERAL SMEAR -NORMOCYTIC,NORMOCHROMIC

SICKLING TEST NEGATIVE

FREE T3 3.86,FREE T4-1.41

D DIMER 2160

DAY 7-

GCS-E2V2M3

INJ. CEFTRAIXONE 1 GM IV BD STARTED

IN VIEW OF UNEXPLAINED LIVER FAILURE N ACETYL CYSTEINE ,IV INFUSION WAS STARTED (600 MG)

WITH SUSPICION OF ANY CEREBRAL EDEMA ,3% NACL INFUSION WAS GIVEN FOR 1 DAY

GASTROENTEROLOGY REFERRAL WAS TAKEN : ACUTE FULMINANT HEPATIC FAILURE ,ADVISED FOR LIVER TRANSPLANTATION BUT PT ATTENDERS WERE NOT AFFORDABLE

DAY 8-

GCS-E1V1M3,VITALS STABLE

 IN VIEW OF ACUTE FULMINANT LIVER FAILURE, HEPATIC ENCEPHALOPATHY PROBABILITY OF MULTISYSTEM INFLAMMATORY SYNDROME (POST COVID) WAS CONSIDERED.

COVID ANTIBODIES WERE SENT WHICH SHOWED COVID ANTIBODY IGG >150(NORMAL IS <1), COVID ANTIBODY TOTAL VIA ELISA 5.85(NORMAL IS <0.8)



TB-12.6, DB-6.5, IB-6.1, AST 402, ALT 82, TP 6.8, ALB 4.1, HB 12.6,TLC 5300, PLT 1.31

AFTER 4 DAYS OF HEPATIC COMA WITH RAISING BILIRUBIN ATTENDERS WERE COUNSELLED ABOUT POOR PROGNOSIS BUT TO OUR SURPRISE BY EVNG 7 PM ON DAY 8 OF ADMISSION PT SENSORIUM IMPROVED DRASTICALLY, SUDDENLY PATIENT WOKE UP AND PT WAS IRRITABLE AND COMPLETELY CAME INTO CONSCIOUS

PT WAS PASSING 2-3 STOOLS /DAY

GCS-E4V3M6

……………………..

DAY 9-

PT RESPONDED TO COMMANDS, ORIENTED TO TIME, PLACE, PERSON, VITALS STABLE

SERUM AMMONIA (sent on day 7 )-108(NORMAL)

RTPCR COVID NEGATIVE (done on day 7)

3% NACL WAS STOPPED AND REST ALL OTHER TREATMENT WAS CONTINUED

AT AROUND 6 PM, PT HAD 1 EPISODE OF TRANSIENT ABNORMAL BEHAVIOUR WITH VISUAL HALLUCINATIONS WHICH SUBSIDED AFTER FEW MINUTES.

DAY 10-

POST COVID ACUTE FULMINANT HEPATIC FAILURE? MISC 

?COOMBS  NEGATIVE HEMOLYTIC ANEMIA

HEAPTIC ENCEPHALOPATHY RESOLVED

COAGULOPATHY REOLVED 

DKA RESOLVED 

THROMBOCYTOPENIA RESOLVING 

METABOLIC SEIZURES(RESOLVED)

PT SLEPT WELL YESTERDAY NIGHT .NO EPISODES OF ABSENCE SEIZURES, NO HALLUCINATIONS ,PASSED STOOLS 2 TIMES YESTERDAY AND ONCE TODAY MRNG

SERIAL LFT MONITORING WAS DONE(TB 12)

DAY 11-

PT HAD NO COMPLAINTS 

PT WAS AMBULATED, REST ALL OTHER TREATMENT CONTINUED

DAY 12-

NO FRESH COMPLAINTS, PASSED STOOLS 2 TIMES PER DAY, SAME TREATMENT CONTINUED

On day 13


On day 15


DAY 13,14,15-

NO FRESH COMPLAINTS, PASSED STOOLS 2-3 TIMES A DAY, SAME TREATMENT CONTINUED AND VITALS STABLE

DAY 16-

ON THE DAY OF DISCHARGE, PT IS CONSCIOUS, COHERENT AND VITALS STABLE

TB 4.08, DB 3.62, AST 51, ALT 142, ALP 205, TP 6.6, ALB 2.9

PT WAS ADVISED TO TAKE EGG WHITES, TO PASS STOOLS 2-3 TIMES /DAY AND REVIEW AFTER 1 WEEK WITH CBP, LFT, PT INR AND APTT

ADVICE AT DISCHARGE- 

ORAL FLUIDS 2-3 LTS/DAY

TAB LEVIPIL 500 MG BD

TAB.UDILIV 300 MG BD FOR 5 DAYS

TAB.RIFAGUT 550 MG  BD

TAB PANTOP 40 MG OD

SYP. HEPAMERZ 10 ML BD

SYP LACTULOSE 10 ML BD( TO PASS 2-3 STOOLS /DAY)

INJ. HAI SC  6U TID

FINAL DIAGNOSIS:

POST COVID 

ACUTE FULMINANT HEPATIC FAILURE WITH INTRA HEPATIC CHOLESTASIS

?MULTI SYSTEMIC INFLAMMATORY SYNDROME IN CHILDREN

?COOMBS  NEGATIVE HEMOLYTIC ANEMIA

HEAPTIC ENCEPHALOPATHY RESOLVED

COAGULOPATHY REOLVED 

DKA RESOLVED 

THROMBOCYTOPENIA RESOLVING 

METABOLIC SEIZURES(RESOLVED)




[13-05-2025 13:13] PPM 1: Thanks!
He waited two years before realising that his inability to retract the foreskin was a problem necessitating consultation?
What's the cause of his phimosis? Balanoposthitis?
What are the findings on local examination?

[14-05-2025 20.01] PA:

PPM 7: 👍
PPM 1: 👍
[14-05-2025 21:57] PPM 2: Current blood sugar trends and insulin doses?
[15-05-2025 06:30] PPM 1: Removed patient identifiers and shared again.
@PPM2 @LA for research interest only, it's interesting that inspite of all our efforts to inculcate deidentification, there is a tendency among our actual working team to still keep sharing patient identifiers in their own unit groups to which we are not allowed entry! I am aware that sharing the patient's name and remembering a patient name may have something to do with empathic bonding but then I feel it's not essential. 
12/5/2
7pm-137mg/dl
           25uNph + 15uHai 
          - ate 1 dosa with chutney 
10pm - 67mg/dl 
 12am - 55mg/dl 
         - 1/2 25%D + 1 banana 
2am - 138 mg/dl 
7am - 130mg/dl 
         - 12uHai + 22 uNph- 9am 
         - 1 dosa with chutney + 1 vada 
 11am - 175mg/dl
1 pm - 219 mg/dl - 15uHai given
          - Rice with curry 
4pm - 144 mg/dl 
7pm - 85mg/dl
         -10uHai+15uNph given
         -ate 3chapathis with curry 
10pm -95mg/dl
1am - 44 mg/dl 
          -1/2 25%D + biscuits given 
2am - 140 mg/dl 
4am - 198 mg/dl
7am - 77 mg/dl -   10uHai+15uNph given 
         ate  1dosa with chutney
10am-178mg/dl
 1pm-194mg/dl- 10uHai 
        -ate  rice with curry
4pm-264mg/dl 
7:30pm - 146 mg/dl -10uHai+10uNph 
                ate 3 chapathis with curry
[15-05-2025 06:32] PPM 1: What was his previous dose before 25N15S?
[15-05-2025 07:58] LA: Sir, 
I think the working team is also not technically sound or actually knows about the meaning of keeping their patients anonymous. Privacy is not only a legal but also a philosophical concept which needs to be addressed properly. Along with this it is essential to make people learn those measures by which they can protect their privacy online.
[15-05-2025 08:04] PPM 1: Yes one of our hope is that through participatory medicine approaches multiple user stakeholders can actually make the working team collective realize the importance of these issues along with the life saving high stakes work they are largely engaged in
[15-05-2025 09:21] PPM 3: You bring up an important point—privacy isn’t just a legal checkbox; it’s a fundamental ethical principle that underpins trust in medical practice. Proper patient anonymity goes beyond compliance with regulations; it requires a deep understanding of the philosophical implications of confidentiality and autonomy. 
A working team that lacks technical expertise in privacy protection risks not only legal repercussions but also undermining the integrity of patient care. The challenge isn’t just enforcing privacy rules but educating both medical professionals and patients on best practices for safeguarding sensitive information, particularly in digital spaces where vulnerabilities abound.
Online privacy education is crucial. From understanding encryption methods to recognizing phishing threats, empowering individuals with the knowledge to protect themselves ensures a stronger defense against breaches. Initiatives like digital literacy programs tailored for healthcare settings could significantly mitigate risks.
Would you say that the issue stems more from a lack of awareness or from systemic gaps in enforcement?
[15-05-2025 09:21] PPM 3: Patient privacy carries profound philosophical implications, touching on autonomy, trust, and the balance between individual rights and societal interests.
1. *Autonomy and Consent* – Privacy is deeply tied to a patient's autonomy, ensuring they have control over their personal health information. Philosophically, this aligns with Kantian ethics, which emphasizes respect for individuals as rational agents capable of making their own decisions.
2. *Trust and Confidentiality* – The physician-patient relationship relies on trust, and breaches of privacy can erode this foundation. From a virtue ethics perspective, confidentiality fosters moral integrity and professional responsibility.
3. *Utilitarian Considerations* – While privacy is crucial, there are cases where sharing patient data benefits public health, such as disease tracking or medical research. This raises utilitarian dilemmas—how do we weigh individual privacy against the greater good?
4. *Social and Cultural Dimensions* – Different cultures interpret privacy differently. In some societies, communal values may override strict individual privacy norms, reflecting a more collectivist ethical framework.
5. *Digital Ethics and AI* – With AI-driven healthcare, privacy concerns extend to algorithmic decision-making and data security. Philosophically, this intersects with debates on technological ethics and the limits of machine-driven analysis in sensitive human contexts.
Would you say the biggest challenge lies in enforcement or in shifting ethical perspectives?
[15-05-2025 09:23] PPM 3: AI has a profound impact on patient privacy and confidentiality, both positively and negatively. Here are some key considerations:
### *Challenges to Privacy*
1. *Data Security Risks* – AI systems rely on vast amounts of patient data, increasing the risk of breaches if security measures are inadequate[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-021-00687-3?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "1").
2. *Re-identification Threats* – Even anonymized data can sometimes be re-identified using advanced AI algorithms, compromising patient confidentiality[43dcd9a7-70db-4a1f-b0ae-981daa162054] (https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-021-00687-3?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "1").
3. *Algorithmic Bias* – AI models trained on biased datasets may inadvertently expose sensitive patient information or make inaccurate predictions[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://www.mdpi.com/2076-3417/14/2/675?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "2").
4. *Regulatory Gaps* – AI development often outpaces legal frameworks, leading to uncertainties in how patient data should be protected[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://arxiv.org/abs/2501.01639?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "3").
### *Privacy Safeguards*
1. *Differential Privacy* – Techniques like encryption and differential privacy help protect patient data while allowing AI to analyze trends[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://www.mdpi.com/2076-3417/14/2/675?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "2").
2. *Federated Learning* – AI models can be trained on decentralized data without exposing individual patient records, enhancing security[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://www.mdpi.com/2076-3417/14/2/675?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "2").
3. *Stronger Oversight* – Calls for systemic regulation emphasize the need for ethical AI implementation and patient agency[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-021-00687-3?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "1").
AI-driven healthcare offers immense benefits, but ensuring robust privacy protections is essential. Would you say the biggest concern is technical vulnerabilities or ethical oversight?
[15-05-2025 09:26] PPM 3: These issues are of importance in our work to recognize on academic and public levels, which are the hottest topics of concern
[15-05-2025 10:06] PPM 1: Thanks. Very useful.
Check out this recent chapter written by @LA👇
Would be nice to have everyone's inputs @PPM5 @PPM4 around her next project where she will be collecting PaJR data to sort out our ethico legal issues. She's a Phd scholar in Law
[15-05-2025 12:34] PPM 2: As with this model of working being thrust onto the working team, are we also thrusting the need to maintain privacy onto them - a model they may not really be interested in?
If you zoom out a bit, WhatsApp encrypts all messages and thus the server or the app cannot know, it's only the same working team (either local or remote) knowing patient details - where does the boundary of privacy end sir?
Local caregiver? Remote caregiver? App provider? PaJR blogs?
[15-05-2025 12:56] PPM 6: 12/5/2
7pm-137mg/dl
           25uNph + 15uHai 
          - ate 1 dosa with chutney 
10pm - 67mg/dl 
 12am - 55mg/dl 
         - 1/2 25%D + 1 banana 
2am - 138 mg/dl 
7am - 130mg/dl 
         - 12uHai + 22 uNph- 9am 
         - 1 dosa with chutney + 1 vada 
 11am - 175mg/dl
1 pm - 219 mg/dl - 15uHai given
          - Rice with curry 
4pm - 144 mg/dl 
7pm - 85mg/dl
         -10uHai+15uNph given
         -ate 3chapathis with curry 
10pm -95mg/dl
1am - 44 mg/dl 
          -1/2 25%D + biscuits given 
2am - 140 mg/dl 
4am - 198 mg/dl
7am - 77 mg/dl -   10uHai+15uNph given 
         ate 1dosa with chutney
10am-178mg/dl
 1pm-194mg/dl- 10uHai 
        -ate rice with curry
4pm-264mg/dl 
7:30pm - 146 mg/dl - 10uHai+10uNph given 
                ate 3 chapathis with curry
10:30pm - 77 mg/dl
2am- 80mg/dl 
7am-97mg/dl - 10UHai+15UNph given 
       -ate 1pesara dosa
10am - 149mg/dl
12:50pm - 141 mg/dl
[15-05-2025 13:01] PPM 1: Very good point!
So if we can assume that our working team will not share the patient's identifiers outside the PaJR group it could work out but it's perhaps not safe to assume that because we have many online users too here who are not part of the working team and besides when an information is shared between three or more one can't predict if it's going to leak hence just like we take universal precautions for all procedures assuming everyone is HIV positive, here too we need to maintain a baseline good clinical practice of ensuring removal of patient identifiers in any PaJR group

No comments:

Post a Comment